|
Patients with Myelodysplastic Syndromes Treated with Azacitidine in Clinical Practice: The AVIDA® Registry
|
Jun 2014
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Heterogeneity in the Myelodysplastic Syndromes: Moving Toward a Better Understanding
|
Jan 2013
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
YAP1 expression in myelodysplastic syndromes and acute leukemias
|
Mar 2014
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia
|
Jan 2017
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Methylation of Promoters of microRNAs and their Host Genes in Myelodysplastic Syndromes.
|
Apr 2013
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Hypomethylating agents in myelodysplastic syndromes and population-level outcomes: a changing landscape or a small dent?
|
Sep 2017
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
The Revised International Prognostic Scoring System (IPSS-R) is not Predictive of Survival in Patients with Secondary Myelodysplastic Syndromes
|
Apr 2015
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
The Myelodysplastic Syndromes (MDS): A personal recollection of four decades of classification and prognostic scoring systems.
|
Apr 2013
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Albumin as a prognostic marker in myelodysplastic syndromes: still relevant after all these years
|
May 2015
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Deacetylase Inhibitors for the Treatment of Myelodysplastic Syndromes
|
Jul 2014
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
